vs
Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and FRANKLIN STREET PROPERTIES CORP (FSP). Click either name above to swap in a different company.
FRANKLIN STREET PROPERTIES CORP is the larger business by last-quarter revenue ($26.0M vs $13.8M, roughly 1.9× FENNEC PHARMACEUTICALS INC.). FRANKLIN STREET PROPERTIES CORP runs the higher net margin — -28.1% vs -34.7%, a 6.6% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs -8.2%). Over the past eight quarters, FRANKLIN STREET PROPERTIES CORP's revenue compounded faster (-8.7% CAGR vs -26.3%).
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
Franklin Street Properties Corp is a Massachusetts-based real estate investment trust (REIT) in the United States. It primarily invests in, owns, and operates high-quality office properties across major U.S. metropolitan markets, serving corporate tenants across various industry segments, and delivers stable long-term returns via rental income and strategic asset management.
FENC vs FSP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $26.0M |
| Net Profit | $-4.8M | $-7.3M |
| Gross Margin | — | 59.4% |
| Operating Margin | -18.5% | -27.9% |
| Net Margin | -34.7% | -28.1% |
| Revenue YoY | 73.8% | -8.2% |
| Net Profit YoY | -141.1% | 14.1% |
| EPS (diluted) | $-0.17 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $26.0M | ||
| Q3 25 | $12.5M | $27.3M | ||
| Q2 25 | $9.7M | $26.7M | ||
| Q1 25 | $8.8M | $27.1M | ||
| Q4 24 | $7.9M | $28.4M | ||
| Q3 24 | $7.0M | $29.7M | ||
| Q2 24 | $7.3M | $30.8M | ||
| Q1 24 | $25.4M | $31.2M |
| Q4 25 | $-4.8M | $-7.3M | ||
| Q3 25 | $-638.0K | $-8.3M | ||
| Q2 25 | $-3.2M | $-7.9M | ||
| Q1 25 | $-1.2M | $-21.4M | ||
| Q4 24 | $-2.0M | $-8.5M | ||
| Q3 24 | $-5.7M | $-15.6M | ||
| Q2 24 | $-5.6M | $-21.0M | ||
| Q1 24 | $12.8M | $-7.6M |
| Q4 25 | — | 59.4% | ||
| Q3 25 | — | 60.9% | ||
| Q2 25 | — | 59.9% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 59.7% | ||
| Q3 24 | — | 61.0% | ||
| Q2 24 | — | 64.2% | ||
| Q1 24 | — | 64.7% |
| Q4 25 | -18.5% | -27.9% | ||
| Q3 25 | -1.5% | -30.5% | ||
| Q2 25 | -28.3% | -29.2% | ||
| Q1 25 | -9.2% | -78.9% | ||
| Q4 24 | -11.8% | -29.9% | ||
| Q3 24 | -74.6% | -52.4% | ||
| Q2 24 | -69.4% | -68.0% | ||
| Q1 24 | 54.2% | -24.0% |
| Q4 25 | -34.7% | -28.1% | ||
| Q3 25 | -5.1% | -30.5% | ||
| Q2 25 | -32.7% | -29.5% | ||
| Q1 25 | -13.3% | -79.1% | ||
| Q4 24 | -25.0% | -30.0% | ||
| Q3 24 | -82.2% | -52.6% | ||
| Q2 24 | -76.5% | -68.2% | ||
| Q1 24 | 50.6% | -24.2% |
| Q4 25 | $-0.17 | $-0.06 | ||
| Q3 25 | $-0.02 | $-0.08 | ||
| Q2 25 | $-0.11 | $-0.08 | ||
| Q1 25 | $-0.04 | $-0.21 | ||
| Q4 24 | $-0.02 | $-0.09 | ||
| Q3 24 | $-0.21 | $-0.15 | ||
| Q2 24 | $-0.20 | $-0.20 | ||
| Q1 24 | $0.41 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.8M | $30.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $35.5M | $607.0M |
| Total Assets | $70.6M | $892.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.8M | $30.6M | ||
| Q3 25 | $21.9M | $31.4M | ||
| Q2 25 | $18.7M | $29.4M | ||
| Q1 25 | $22.7M | $30.2M | ||
| Q4 24 | $26.6M | $41.1M | ||
| Q3 24 | $40.3M | $40.9M | ||
| Q2 24 | $43.1M | $30.2M | ||
| Q1 24 | $51.2M | $34.2M |
| Q4 25 | — | — | ||
| Q3 25 | $19.4M | — | ||
| Q2 25 | $19.4M | — | ||
| Q1 25 | $19.4M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | $32.1M | — | ||
| Q2 24 | $31.8M | — | ||
| Q1 24 | $31.3M | — |
| Q4 25 | $35.5M | $607.0M | ||
| Q3 25 | $-4.5M | $615.3M | ||
| Q2 25 | $-7.5M | $624.7M | ||
| Q1 25 | $-5.9M | $633.4M | ||
| Q4 24 | $-5.9M | $655.9M | ||
| Q3 24 | $-5.2M | $665.4M | ||
| Q2 24 | $-1.4M | $682.1M | ||
| Q1 24 | $3.0M | $703.9M |
| Q4 25 | $70.6M | $892.9M | ||
| Q3 25 | $49.3M | $901.0M | ||
| Q2 25 | $44.9M | $903.2M | ||
| Q1 25 | $46.4M | $916.4M | ||
| Q4 24 | $44.9M | $946.9M | ||
| Q3 24 | $58.9M | $981.5M | ||
| Q2 24 | $63.2M | $1.0B | ||
| Q1 24 | $69.2M | $1.0B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.40× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $3.8M |
| Free Cash FlowOCF − Capex | — | $-12.7M |
| FCF MarginFCF / Revenue | — | -48.6% |
| Capex IntensityCapex / Revenue | — | 63.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-25.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | $3.8M | ||
| Q3 25 | $1.5M | $8.3M | ||
| Q2 25 | $-3.7M | $-2.9M | ||
| Q1 25 | $-4.3M | $-5.5M | ||
| Q4 24 | $-1.5M | $9.0M | ||
| Q3 24 | $-2.2M | $14.5M | ||
| Q2 24 | $-8.4M | $-648.0K | ||
| Q1 24 | $39.0M | $-7.1M |
| Q4 25 | — | $-12.7M | ||
| Q3 25 | — | $3.0M | ||
| Q2 25 | — | $-5.7M | ||
| Q1 25 | — | $-9.9M | ||
| Q4 24 | — | $-16.2M | ||
| Q3 24 | — | $8.6M | ||
| Q2 24 | — | $-5.1M | ||
| Q1 24 | — | $-15.8M |
| Q4 25 | — | -48.6% | ||
| Q3 25 | — | 11.0% | ||
| Q2 25 | — | -21.5% | ||
| Q1 25 | — | -36.7% | ||
| Q4 24 | — | -57.2% | ||
| Q3 24 | — | 29.1% | ||
| Q2 24 | — | -16.7% | ||
| Q1 24 | — | -50.8% |
| Q4 25 | — | 63.0% | ||
| Q3 25 | — | 19.4% | ||
| Q2 25 | — | 10.7% | ||
| Q1 25 | — | 16.4% | ||
| Q4 24 | — | 88.9% | ||
| Q3 24 | — | 19.6% | ||
| Q2 24 | — | 14.6% | ||
| Q1 24 | — | 28.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 3.04× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
